Literature DB >> 18061280

Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.

Simona D'Aguanno1, Alessandra Barassi, Santina Lupisella, Gianlodovico Melzi d'eril, Piero Del Boccio, Damiana Pieragostino, Francesco Pallotti, Valerio Carelli, Maria Lucia Valentino, Rocco Liguori, Patrizia Avoni, Sergio Bernardini, Domenico Gambi, Andrea Urbani, Giorgio Federici.   

Abstract

Leber's hereditary optic neuropathy (LHON) is a genetic disease leading to the loss of central vision and optic nerve atrophy. The existence of occasional cases of LHON patients developing a Multiple Sclerosis (MS)-like illness and the hypothesis that mtDNA variants may be involved in MS suggest the possibility of some common molecular mechanisms linking the two diseases. We have pursued a comparative proteomics approach on cerebrospinal fluid (CSF) samples from LHON and MS patients, as well as healthy donors by employing 2-DE gel separations coupled to MALDI-TOF-MS and nLC-MS/MS investigations. 7 protein spots showed significant differential distribution among the three groups. Both CSF of LHON or MS patients are characterized by lower level of transthyretin dimer adduct while a specific up regulation of Apo A-IV was detected in LHON CSF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061280     DOI: 10.1016/j.jneuroim.2007.10.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Mimicry between mitochondrial disorder and multiple sclerosis.

Authors:  Josef Finsterer; Romana Höftberger; Claudia Stöllberger; Boris Rolinski
Journal:  Metab Brain Dis       Date:  2012-02-05       Impact factor: 3.584

2.  Analysis of the mitochondrial proteome in multiple sclerosis cortex.

Authors:  Laurie Broadwater; Ashish Pandit; Robert Clements; Sausan Azzam; Jonathan Vadnal; Michael Sulak; V Wee Yong; Ernest J Freeman; Roger B Gregory; Jennifer McDonough
Journal:  Biochim Biophys Acta       Date:  2011-02-02

3.  Late-onset progressive visual loss in a man with unusual MRI findings: MS, Harding's, Leber's or Leber's Plus?

Authors:  N Cawley; A Molloy; L Cassidy; N Tubridy
Journal:  Ir J Med Sci       Date:  2010-10-01       Impact factor: 1.568

Review 4.  Proteomics in Multiple Sclerosis: The Perspective of the Clinician.

Authors:  Dániel Sandi; Zsófia Kokas; Tamás Biernacki; Krisztina Bencsik; Péter Klivényi; László Vécsei
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

Review 5.  A neurodegenerative perspective on mitochondrial optic neuropathies.

Authors:  Patrick Yu-Wai-Man; Marcela Votruba; Florence Burté; Chiara La Morgia; Piero Barboni; Valerio Carelli
Journal:  Acta Neuropathol       Date:  2016-09-30       Impact factor: 17.088

6.  Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.

Authors:  Ada Fiorini; Tatiana Koudriavtseva; Elona Bucaj; Raffaella Coccia; Cesira Foppoli; Alessandra Giorgi; M Eugenia Schininà; Fabio Di Domenico; Federico De Marco; Marzia Perluigi
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

7.  Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  Shilian Liu; Shumei Bai; Zhaoyu Qin; Yinrong Yang; Yazhou Cui; Yanjiang Qin
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

Review 8.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.